SG11202010136UA - Treatments - Google Patents
TreatmentsInfo
- Publication number
- SG11202010136UA SG11202010136UA SG11202010136UA SG11202010136UA SG11202010136UA SG 11202010136U A SG11202010136U A SG 11202010136UA SG 11202010136U A SG11202010136U A SG 11202010136UA SG 11202010136U A SG11202010136U A SG 11202010136UA SG 11202010136U A SG11202010136U A SG 11202010136UA
- Authority
- SG
- Singapore
- Prior art keywords
- treatments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1808563.9A GB201808563D0 (en) | 2018-05-24 | 2018-05-24 | Treatments |
PCT/IB2019/054293 WO2019224780A1 (en) | 2018-05-24 | 2019-05-23 | Treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202010136UA true SG11202010136UA (en) | 2020-11-27 |
Family
ID=62812513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202010136UA SG11202010136UA (en) | 2018-05-24 | 2019-05-23 | Treatments |
Country Status (12)
Country | Link |
---|---|
US (1) | US20210213016A1 (en) |
EP (1) | EP3801508A1 (en) |
JP (1) | JP2021525263A (en) |
CN (1) | CN112165941A (en) |
AU (1) | AU2019274813A1 (en) |
BR (1) | BR112020023972A2 (en) |
CA (1) | CA3100428A1 (en) |
GB (1) | GB201808563D0 (en) |
MX (1) | MX2020012622A (en) |
SG (1) | SG11202010136UA (en) |
WO (1) | WO2019224780A1 (en) |
ZA (1) | ZA202006321B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201808564D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Treatments |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030129208A1 (en) * | 2002-01-07 | 2003-07-10 | Alberts David S. | Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses |
GB201115635D0 (en) * | 2011-09-09 | 2011-10-26 | Univ Liverpool | Compositions of lopinavir and ritonavir |
AU2014338707B2 (en) * | 2013-10-23 | 2020-06-04 | The University Of Manchester | Treatment of cancer and benign proliferative disorders |
-
2018
- 2018-05-24 GB GBGB1808563.9A patent/GB201808563D0/en not_active Ceased
-
2019
- 2019-05-23 JP JP2020565852A patent/JP2021525263A/en active Pending
- 2019-05-23 WO PCT/IB2019/054293 patent/WO2019224780A1/en unknown
- 2019-05-23 US US17/055,067 patent/US20210213016A1/en active Pending
- 2019-05-23 CN CN201980034878.8A patent/CN112165941A/en active Pending
- 2019-05-23 CA CA3100428A patent/CA3100428A1/en active Pending
- 2019-05-23 SG SG11202010136UA patent/SG11202010136UA/en unknown
- 2019-05-23 BR BR112020023972-0A patent/BR112020023972A2/en unknown
- 2019-05-23 EP EP19731347.1A patent/EP3801508A1/en active Pending
- 2019-05-23 AU AU2019274813A patent/AU2019274813A1/en active Pending
- 2019-05-23 MX MX2020012622A patent/MX2020012622A/en unknown
-
2020
- 2020-10-12 ZA ZA2020/06321A patent/ZA202006321B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2019224780A1 (en) | 2019-11-28 |
GB201808563D0 (en) | 2018-07-11 |
AU2019274813A1 (en) | 2020-12-10 |
CA3100428A1 (en) | 2019-11-28 |
MX2020012622A (en) | 2021-01-29 |
US20210213016A1 (en) | 2021-07-15 |
ZA202006321B (en) | 2022-01-26 |
CN112165941A (en) | 2021-01-01 |
EP3801508A1 (en) | 2021-04-14 |
JP2021525263A (en) | 2021-09-24 |
BR112020023972A2 (en) | 2021-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277336A (en) | Combination therapy | |
GB201804255D0 (en) | Macrophage-based therapy | |
GB201800274D0 (en) | Novel treatments | |
GB201813876D0 (en) | Treatment | |
GB201819853D0 (en) | Therapy | |
GB201820660D0 (en) | Cancer treatments | |
IL281792A (en) | Treatment methods | |
IL280968A (en) | Combination therapy | |
IL279908A (en) | Combination therapy | |
GB201800546D0 (en) | Treatment | |
GB201701315D0 (en) | Novel treatments | |
GB201808564D0 (en) | Treatments | |
IL281839A (en) | Treatment methods | |
ZA202006321B (en) | Treatments | |
IL280729A (en) | Combination therapy | |
GB201820215D0 (en) | Treatments etc | |
IL288526A (en) | Thiarabine- and thiarabine prodrug-based treatments | |
GB201801982D0 (en) | Novel treatments | |
GB201917908D0 (en) | Novel treatments | |
GB201913636D0 (en) | Novel treatments | |
GB201814905D0 (en) | Treatment | |
GB201904714D0 (en) | Novel treatments | |
IL262221A (en) | Treat ments forcahcers etc | |
GB201820895D0 (en) | Therapy | |
GB201817385D0 (en) | Therapy |